Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Key Ratios

Key Ratios

Price & Volume

Recent Price $9.85
52 Week High $14.60
52 Week Low $5.50
Volume (10 Day Average) (Mil) $0.14
Beta $-0.16

Dividends

Yield (%) --
Ex-Dividend Date
Dividend Rate --%

Financial Strength

Quick Ratio (MRQ) --
Current Ratio (MRQ) $6.83
LT Debt to Equity (MRQ) (%) --
Total Debt to Equity (MRQ) (%) --

Valuation

P/E (TTM) --
Price to Revenue (TTM) $217.94
Price to Cash Flow (TTM) --
Price to Book (MRQ) $2.65

Per Share

Revenue/Share (TTM) $0.06
EPS Fully Diluted (MRQ) $-0.67
Book Value/Share (MRQ) $3.71
Cash Flow/Share (TTM) $-2.33
Cash (MRQ) $3.57

Management Effectiveness

Return on Equity (TTM) (%) -50.43
Return on Assets (TTM) (%) -44.70
Return on Investment (TTM) (%) -50.27

Profitability

Operating Margin (TTM) (%) -3,909.87
Net Profit Margin (TTM) (%) -3,860.49
Gross Margin (TTM) (%) --


Copyright 2017 - Stemline Therapeutics, Inc. All rights reserved